A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Apalutamide is under clinical development by Johnson & Johnson and currently in Phase II for Prostate Cancer. According to GlobalData, Phase II drugs for Prostate Cancer have a 23% phase transition ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

After skin cancer, prostate cancer is the most common cancer among men in the U.S., and 20% to 30% of men who beat it once ...

EMJ is delighted to introduce Axel Heidenreich, Professor and Director at the University of Cologne, Germany, who spoke to us ...

After a year beset with illness, Te Pāti Māori's former co-leader urges New Zealanders to take their wellbeing seriously ...

King Charles III was diagnosed with cancer earlier this year after a hospital visit for an enlarged prostate. This is how treatment is going.

Discovery May Open New Way to Attack Prostate Cancer Dec. 3, 2024 — A special protein can play a key role in the fight against certain types of prostate cancer. Until now, treatments have ...

King Charles’s cancer treatment will continue into the New Year after almost a year’s battle with the disease, according to ...